- Home
- ARQT vs FLOC Comparison
ARQT vs FLOC Comparison
Compare ARQT & FLOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- FLOC
- Stock Information
- Founded
- ARQT 2016
- FLOC 1996
- Country
- ARQT United States
- FLOC United States
- Employees
- ARQT N/A
- FLOC N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- FLOC Metal Fabrications
- Sector
- ARQT Health Care
- FLOC Industrials
- Exchange
- ARQT Nasdaq
- FLOC Nasdaq
- Market Cap
- ARQT 1.6B
- FLOC 1.7B
- IPO Year
- ARQT 2020
- FLOC 2025
- Fundamental
- Price
- ARQT $13.52
- FLOC $21.51
- Analyst Decision
- ARQT Strong Buy
- FLOC Strong Buy
- Analyst Count
- ARQT 6
- FLOC 5
- Target Price
- ARQT $18.80
- FLOC $33.60
- AVG Volume (30 Days)
- ARQT 2.1M
- FLOC 278.0K
- Earning Date
- ARQT 05-06-2025
- FLOC 05-13-2025
- Dividend Yield
- ARQT N/A
- FLOC 0.38%
- EPS Growth
- ARQT N/A
- FLOC N/A
- EPS
- ARQT N/A
- FLOC 10.41
- Revenue
- ARQT $212,819,000.00
- FLOC $535,278,000.00
- Revenue This Year
- ARQT $57.99
- FLOC $58.16
- Revenue Next Year
- ARQT $41.24
- FLOC $12.91
- P/E Ratio
- ARQT N/A
- FLOC $2.00
- Revenue Growth
- ARQT 100.03
- FLOC 119.99
- 52 Week Low
- ARQT $6.99
- FLOC $16.69
- 52 Week High
- ARQT $17.75
- FLOC $30.50
- Technical
- Relative Strength Index (RSI)
- ARQT 42.59
- FLOC N/A
- Support Level
- ARQT $12.42
- FLOC N/A
- Resistance Level
- ARQT $15.67
- FLOC N/A
- Average True Range (ATR)
- ARQT 0.87
- FLOC 0.00
- MACD
- ARQT -0.03
- FLOC 0.00
- Stochastic Oscillator
- ARQT 33.69
- FLOC 0.00
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About FLOC Flowco Holdings Inc. Class A Common Stock
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.